Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-24-052262

Options or other derivatives

  • CEO and CFO acquired 1,173,731 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patel Snehal CEO and CFO 2024-12-24 Grant or award · Stock Options +1,148,723 2,222,454 D
Patel Snehal CEO and CFO 2024-12-24 Grant or award · Stock Options +25,008 2,247,462 I
Loading xslF345X05/ownership.xml…